Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition of amikacin sulfate and medical application of pharmaceutical composition

A technology of amikacin sulfate and a composition, applied in the field of biomedicine, can solve the problems such as the related reports on chronic myeloid leukemia and the like, and achieve the effect of improving the therapeutic effect

Inactive Publication Date: 2016-07-06
WENZHOU JUYICHUANG TECH CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] So far, there has been no report on the correlation between the pharmaceutical composition of amikacin sulfate and chronic myelogenous leukemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition of amikacin sulfate and medical application of pharmaceutical composition
  • Pharmaceutical composition of amikacin sulfate and medical application of pharmaceutical composition
  • Pharmaceutical composition of amikacin sulfate and medical application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Compound (I) Separation Preparation and Structure Confirmation

[0019] Sources of reagents: ethanol, petroleum ether, ethyl acetate, n-butanol, and dichloromethane were of analytical grade, purchased from Shanghai Lingfeng Chemical Reagent Co., Ltd. Methanol, of analytical grade, were purchased from Jiangsu Hanbang Chemical Reagent Co., Ltd.

[0020] Separation method: (a) Grind the dry root and rhizome (5kg) of Radix isatidis, extract with 75% ethanol under hot reflux (20L×3 times), combine the extracts, concentrate until no alcohol smell (4L), and then use petroleum ether ( 4L×3 times), ethyl acetate (4L×3 times) and water-saturated n-butanol (4L×3 times) were extracted to obtain petroleum ether extract, ethyl acetate extract and n-butanol extract respectively; (b ) Ethyl acetate extract in step (a) is removed with AB-8 type macroporous resin, first elute 8 column volumes with 6% ethanol, then elute 8 column volumes with 70% ethanol, collect 70% eluent Re...

Embodiment 2

[0023] Example 2: Therapeutic effect on chronic myelogenous leukemia

[0024] 1. Materials and Instruments

[0025] K562 cells were provided by Shanghai Institute of Biological Cells, Chinese Academy of Sciences. Compound (I) is self-made, and the HPLC normalized purity is greater than 98%. RPMI-1640 dry powder medium was purchased from Gibco. Calf serum was purchased from Hangzhou Sijiqing Institute of Bioengineering Materials. Penicillin and streptomycin were purchased from Huabei Pharmaceutical Factory. Glutamine, MTT, DMSO were purchased from AMRESCO. Annexinv-FITC cell apoptosis detection kit was purchased from Nanjing KGI Biotechnology Development Co., Ltd. MOPS, Rnasin, agarose, olfactory ethidium, bromophenol blue Huamei Bioengineering Company Huamei Bioengineering Company.

[0026] CO 2 Incubator (Thermo Company, USA), ultra-clean bench (Suzhou Purification Equipment Factory), magnetic stirrer (Shanghai Nanhui Telecommunication Equipment Factory), inverted micr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition of amikacin sulfate and medical application of the pharmaceutical composition.The pharmaceutical composition comprises the amikacin sulfate and a natural compound (I) which is separated from the dried roots and rhizomes of radix isatidis and is novel in structure.When the amikacin sulfate and the natural compound (I) act independently, the curative effect on chronic granulocytic leukemia is weak; when the amikacin sulfate and the natural compound (I) act in a combined manner, the curative effect on the chronic granulocytic leukemia is increased greatly.The pharmaceutical composition can be developed into medicine for treating the chronic granulocytic leukemia.Compared with the prior art, the pharmaceutical composition is outstanding in substantial characteristics and evident in progress.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to the treatment of chronic myeloid leukemia, in particular to a pharmaceutical composition of amikacin sulfate and its therapeutic effect on chronic myeloid leukemia. Background technique [0002] Amikacin sulfate is a semi-synthetic aminoglycoside antibiotic with a similar antibacterial spectrum to gentamicin, and is effective against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Proteus. This product is also effective against other aminoglycoside antibiotic-resistant strains. It is mainly used clinically for pyelonephritis, urinary tract infection, respiratory tract and lung infection, and sepsis caused by sensitive bacteria. [0003] Chronic myeloid leukemia is a malignant tumor that affects the blood and bone marrow. It is characterized by the production of a large number of immature white blood cells, which accumulate in the bone marrow and inhibit the normal hema...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/14A61K31/4375A61K31/7036A61K36/195A61K36/315A61P35/02
CPCC07D471/14A61K31/4375A61K31/7036A61K36/195A61K36/315A61K2236/333A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner WENZHOU JUYICHUANG TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com